Department of Cancer Studies, King's College London, Guy's Hospital, London, UK.
University of South Florida, College of Public Health, Tampa, USA.
Diabet Med. 2017 Oct;34(10):1354-1360. doi: 10.1111/dme.13411. Epub 2017 Aug 1.
This study examined the outputs of research papers in diabetes from 31 European countries between 2002 and 2013, and their funding.
Diabetes research papers in the Web of Science were identified by means of a filter based on journals and title words. For 2009-2013 papers, the funders were coded to show their sector and nationality.
Europe published 40 547 diabetes papers in the 12 years between 2002 and 2013. Denmark, Sweden and Finland published the most relative to their wealth, but the UK published the most absolutely despite an apparently low burden (as measured by disability-adjusted life years). The largest source of funding was government (30%), followed by the non-profit sector (18%) and industry (13%). The European Commission supported 2.7% of papers, but more in Latvia (33%) and Estonia (16%). Based on an estimated cost per paper of €260 000, the annual research expenditure in Europe was approximately €986 million in 2013.
The European diabetes burden in disability-adjusted life years increased by one third between 2002 and 2012, but its output of research papers has decreased from 44% to 36% of the world total. This decrease needs to be reviewed in the context of European non-communicable disease research policy.
本研究考察了 2002 年至 2013 年间 31 个欧洲国家发表的糖尿病领域研究论文及其资金情况。
通过基于期刊和标题词的过滤器，在 Web of Science 中确定糖尿病研究论文。对于 2009-2013 年的论文，对资助者进行编码以显示其部门和国籍。
欧洲在 2002 年至 2013 年的 12 年间发表了 40547 篇糖尿病论文。丹麦、瑞典和芬兰的相对财富发表论文最多，但英国尽管负担明显较低（以残疾调整生命年衡量），但绝对发表论文最多。最大的资金来源是政府（30%），其次是非营利部门（18%）和工业（13%）。欧盟委员会支持了 2.7%的论文，但在拉脱维亚（33%）和爱沙尼亚（16%）的支持更多。根据每篇论文估计的 260000 欧元成本，2013 年欧洲每年的研究支出约为 9.86 亿欧元。
2002 年至 2012 年期间，欧洲按残疾调整生命年计算的糖尿病负担增加了三分之一，但该地区的研究论文产出已从占世界总数的 44%降至 36%。在欧洲非传染性疾病研究政策的背景下，需要对这一下降情况进行审查。
